Multiple relapses of hyperthyroidism after thyroid surgeries in a patient with long term follow-up of sporadic non-autoimmune hyperthyroidism

Experimental and Clinical Endocrinology and Diabetes

Volumn 116, Issue 6, 2008, Pages 341-346

  Bircan, R ^c   Miehle, K ^b   Mladenova, C ^d   Ivanova, R ^e   Sarafova, A ^e   Borissova, A M ^e   Lublinghoff J ^b   Paschke, R ^a,b  

^a UNIVERSITY HOSPITAL LEIPZIG   (Germany)

^b UNIVERSITY OF LEIPZIG   (Germany)

^c MARMARA UNIVERSITY   (Turkey)

^d MEDICAL UNIVERSITY OF SOFIA   (Bulgaria)

^e UNIVERSITY HOSPITAL ALEXANDROVSKA   (Bulgaria)

Author keywords

Hormones; Non autoimmune hyperthyroidism; Receptors; Signal transduction; Sporadic germline mutation; Thyrotropin

Indexed keywords

ANTITHYROID AGENT; ASPARTIC ACID; LEVOTHYROXINE; LIOTHYRONINE; PROPRANOLOL; PROPYLTHIOURACIL; RADIOACTIVE IODINE; THIAMAZOLE; THYROTROPIN; THYROTROPIN RECEPTOR; THYROXINE; TYROSINE;

ADOLESCENT; ADULT; AMINO ACID SUBSTITUTION; ANAMNESIS; ARTICLE; CASE REPORT; CHILD; CLINICAL FEATURE; CODON; CRANIOFACIAL SYNOSTOSIS; DISEASE CONTROL; DISEASE COURSE; DRUG DISTRIBUTION; DRUG DOSE INCREASE; DRUG DOSE REDUCTION; DRUG WITHDRAWAL; FOLLOW UP; GENE MUTATION; GENE SEQUENCE; HOSPITAL DISCHARGE; HUMAN; HYPERTHYROIDISM; INFANT; LABORATORY TEST; LONG TERM CARE; MALE; NEUROPSYCHOLOGICAL TEST; PHYSICAL EXAMINATION; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN LOCALIZATION; RECURRENT DISEASE; REOPERATION; SKULL RADIOGRAPHY; THYROID SCINTISCANNING; THYROIDECTOMY; TISSUE GROWTH; TREATMENT OUTCOME;

ADULT; AMINO ACID SUBSTITUTION; DNA; FOLLOW-UP STUDIES; GENE AMPLIFICATION; HUMANS; HYPERTHYROIDISM; MALE; POLYMERASE CHAIN REACTION; POLYMORPHISM, SINGLE NUCLEOTIDE; RECEPTORS, THYROTROPIN; RECURRENCE; THYROIDECTOMY;

EID: 46749139052     PISSN: 09477349     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2007-1004566     Document Type: Article

References (28)

1. Borgel K, Pohlenz J, Koch HG, Bramswig JH. Long-term Carbimazole treatment of neonatal nonautoimmune hyperthyroidism due to a new activating TSH receptor gene mutation (Ala428Val). Horm Res 2005; 64: 203-208
2. Claeysen S, Govaerts C, Lefort A, Van SJ, Costagliola S, Pardo L, Vassart G. A conserved Asn in TM7 of the thyrotropin receptor is a common requirement for activation by both mutations and its natural agonist. FEBS Lett 2002 April 24; 517: 195-200
3. Roux N de, Polak M, Couet J, Leger J, Czemichow P, Milgrom E, Misrahi M. A neomutation of the thyroid-stimulating hormone receptor in a severe neonatal hyperthyroidism. J Clin Endocrinol Metab 1996; 8: 2023-2026
4. Duprez L, Parma J, Costagliola S, Hermans J, Sande J Van, Dumont JE, Vassart G. Constitutive activation of the TSH receptor by spontaneous mutations affecting the N-terminal extracellular domain. FEBS Lett 1997; 409: 469-474
5. Esapa CT, Duprez L, Ludgate M, Mustafa MS, Kendall-Taylor P, Vassart G, Harris PE. A novel thyrotropin receptor mutation in an infant with severe thyrotoxicosis. Thyroid 1999; 9: 1005-1010
6. Fuhrer D, Lachmund P, Nebel IT, Paschke R. The thyrotropin receptor mutation database: update 2003. Thyroid 2003; 13; 1123-1126
7. Fuhrer D, Mix M, Wonerow P, Richter I, Willgerodt H, Paschke R. Variable phenotype associated with Ser505Asn-activating thyrotropin-receptor germline mutation. Thyroid 1999; 9: 757-761
8. Fuhrer D, Wonerow P, Willgerodt H, Paschke R. Identification of a new thyrotropin receptor germline mutation (Leu629Phe) in a family with neonatal onset of autosomal dominant nonautoimmune hyperthyroidism. J Clin Endocrinol Metab 1997; 82: 4234-4238
9. Gozu HI, Bircan R, Krohn K, Mueller S, Ekinci G, Yavuzer D, Sargin H, Sargin M, Orbay E, Cirakoglu B, Paschke R. A further germline variant in the extracellular domain of the TSH-receptor and reexamination of autosomal dominant non-autoimmune hyperthyroidism. Eur J Endocrinol 2007; in: revision
10. Gozu HI, Bircan R, Krohn K, Muller S, Vural S, Gezen C, Sargin H, Yavuzer D, Sargin M, Cirakoglu B, Paschke R. Similar prevalence of somatic TSH receptor and Gsalpha mutations in toxic thyroid nodules in geographical regions with different iodine supply in Turkey. Eur J Endocrinol 2006; 155: 535-545
11. Gruters A, Schoneberg T, Biebermann H, Krude H, Krohn HP, Dralle H, Gudermann T. Severe congenital hyperthyroidism caused by a neo mutation in the extracellular portion of the thyrotropin receptor. J Clin Endocrinol Metab 1998; 83: 1431-1436
12. Ho SC, Sande J Van, Lefort A, Vassart G, Costagliola S. Effects of mutations involving the highly conserved S281HCC motif in the extracellular domain of the thyrotropin (TSH) receptor on TSH binding and constitutive activity. Endocrinology 2001; 142: 2760-2767
13. Holzapfel HP, Wonerow P, Petrykowski W von, Henschen M, Scherbaum WA, Pascke R. Sporadic congenital hyperthyroidism due to a spontaneous germline mutation in the thyrotropin receptor gene. J Clin Endocrinol Metab 1997; 82: 3879-3884
14. Jaeschke H, Neumann S, Kleinau G, Mueller S, Claus M, Krause G, Paschke R. An aromatic environment in the vicinity of serine 281 is a structural requirement for thyrotropin receptor function. Endocrinology 2006; 147: 1753-1760
15. Kopp P, Jameson JL, Roe TF. Congenital nonautoimmune hyperthyroidism in a nonidentical twin caused by a sporadic germline mutation in the thyrotropin receptor gene. Thyroid 1997; 7: 765-769
16. Kopp P, Sande J van, Parma J, Duprez L, Gerber H, Joss E, Jameson JL, Dumont JE, Vassart G. Brief report: Congenital hyperthyroidism caused by a mutation in the thyrotropin-receptor gene. N Engl J Med 1995; 332: 150-154
17. Kosugi S, Shenker A, Mori T. Constitutive activation of cyclic AMP but not phosphatidylinositol signaling caused by four mutations in the 6th transmembrane helix of the human thyrotropin receptor. FEBS Lett 1994; 356: 291-294
18. Lavard L, Sehested A, Brock Jacobsen B, Muller J, Perrild H, Feldt-Rasmussen U, Parma J, Vassart G. Long-term follow-up of an infant with thyrotoxicosis due to germline mutation of the TSH receptor gene (Met453Thr). Horm Res 1999; 51: 43-46
19. Leclere J, Bene MC, Aubert V, Klein M, Pascal-Vigneron V, Weryha G, Faure G. Clinical consequences of activating germline point-mutations of the TSH receptor, the concept of toxic hyperplasia. Horm Res 1997; 47: 158-162
20. Nishihara E, Fukata S, Hishinuma A, Kudo T, Ohye H, Ito M, Kubota S, Amino N, Kuma K, Miyauchi A. Sporadic congenital hyperthyroidism due to a germline mutation in the thyrotropin receptor gene (Leu512Gln) in a Japanese patient. Endocr J 2006; 53: 735-740
21. Parma J, Duprez L, Sande J Van, Hermans J, Rocmans P, Vliet G Van, Costagliola S, Rodien P, Dumont JE, Vassart G. Diversity and prevalence of somatic mutations in the thyrotropin receptor and Gs alpha genes as a cause of toxic thyroid adenomas. J Clin Endocrinol Metab 1997; 82: 2695-2701
22. 2+ cascades. Mol Endocrinol 1995; 9: 725-733
23. Porcellini A, Ciullo I, Laviola L, Amabile G, Fenzi G, Avvedimento VE. Novel mutations of thyrotropin receptor gene in thyroid hyperfunctioning adenomas. Rapid identification by fine needle aspiration biopsy. J Clin Endocrinol Metab 1994; 79: 657-661
24. Russo D, Tumino S, Arturi F, Vigneri P, Grasso G, Pontecorvi A, Filetti S, Belfiore A. Detection of an activating mutation of the thyrotropin receptor in a case of an autonomously hyperfunctioning thyroid insular carcinoma. J Clin Endocrinol Metab 1997; 82: 3906-3908
25. Schwab KO, Gerlich M, Broeker M, Sohlemann P, Derwahl M, Lohse MJ. Constitutively active germline mutation of the thyrotropin receptor gene as a cause of congenital hyperthyroidism. J Pediatr 1997; 131: 899-904
26. Tonacchera M, Agretti P, Rosellini V, Ceccarini G, Perri A, Zampolli M, Longhi R, Larizza D, Pinchera A, Vitti P, Chiovato L. Sporadic nonautoimmune congenital hyperthyroidism due to a strong activating mutation of the thyrotropin receptor gene. Thyroid 2000; 10: 859-863
27. Trulzsch B, Krohn K, Wonerow P, Chey S, Holzapfel HP, Ackermann F, Fuhrer D, Paschke R. Detection of thyroid-stimulating hormone receptor and Gsalpha mutations: in 75 toxic thyroid nodules by denaturing gradient gel electrophoresis. J Mol Med 2001; 78: 684-691
28. Wonerow P, Chey S, Fuhrer D, Holzapfel HP, Paschke R. Functional characterization of five constitutively activating thyrotrophin receptor mutations. Clin Endocrinol (Oxf) 2000; 53: 461-468